The Tumor Pathology of Genetically Engineered Mice: A New Approach to Molecular Pathology

[1]  neurocirujo.  Endocrine system the pituitary gland. , 2007, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  Therese Sørlie,et al.  Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. , 2004, European Journal of Cancer.

[3]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[4]  Christopher H. Contag,et al.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.

[5]  R. Cardiff.  Pathology of Mouse Models of Cancer , 2004 .

[6]  M. Clarke,et al.  Self-renewal and solid tumor stem cells , 2004, Oncogene.

[7]  L. Harrington.  Does the reservoir for self-renewal stem from the ends? , 2004, Oncogene.

[8]  J. Dick,et al.  Concepts of human leukemic development , 2004, Oncogene.

[9]  J. Gregg,et al.  Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. , 2004, Molecular cancer research : MCR.

[10]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[11]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[12]  S. Cramer.  Diagnostic accuracy of second-opinion diagnoses based on still images. , 2004, Human pathology.

[13]  R. Cardiff,et al.  Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin‐RAS transgenic mice , 2004, The Prostate.

[14]  Jose J. Galvez,et al.  Mouse models of human cancers (part 3). , 2004, Comparative medicine.

[15]  S. Hilsenbeck,et al.  Somatic Mutation of p53 Leads to Estrogen Receptor α-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis , 2004, Cancer Research.

[16]  K. Jain,et al.  Applications of biochips: from diagnostics to personalized medicine. , 2004, Current opinion in drug discovery & development.

[17]  Giovanni Parmigiani,et al.  A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer , 2004, Clinical Cancer Research.

[18]  E. Schmidt.  The role of c-myc in regulation of translation initiation , 2004, Oncogene.

[19]  R. Cardiff,et al.  Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.

[20]  Jules J Berman,et al.  Tumor classification: molecular analysis meets Aristotle , 2004, BMC Cancer.

[21]  M. Rubin,et al.  Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.

[22]  N. Greenberg,et al.  Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype , 2004, Journal of cellular biochemistry.

[23]  Jose J. Galvez,et al.  Mouse models of human cancers (Part 2). , 2004, Comparative medicine.

[24]  R. Cardiff,et al.  Angiogenic Acceleration of Neu Induced Mammary Tumor Progression and Metastasis , 2004, Cancer Research.

[25]  Jose J. Galvez,et al.  Validation: The New Challenge for Pathology , 2004, Toxicologic pathology.

[26]  H. Varmus,et al.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Sugimoto,et al.  PI3K/Akt and apoptosis: size matters , 2003, Oncogene.

[28]  R. Cardiff,et al.  Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors , 2003, Molecular and Cellular Biology.

[29]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[30]  José L. V. Mejino,et al.  A reference ontology for biomedical informatics: the Foundational Model of Anatomy , 2003, J. Biomed. Informatics.

[31]  J. Downing,et al.  Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. , 2003, Blood.

[32]  A. Berns,et al.  Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.

[33]  J. Minna,et al.  A big step in the study of small cell lung cancer. , 2003, Cancer cell.

[34]  R. Cardiff,et al.  Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. , 2003, Cancer research.

[35]  Hiroki Nagase,et al.  Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human , 2003, Nature Genetics.

[36]  R. Cardiff,et al.  Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. , 2003, Cancer research.

[37]  K. Desai,et al.  Interrogating Mouse Mammary Cancer Models: Insights from Gene Expression Profiling , 2003, Journal of Mammary Gland Biology and Neoplasia.

[38]  R. Cardiff,et al.  Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation , 2003, Oncogene.

[39]  T. Dragani.  10 years of mouse cancer modifier loci: human relevance. , 2003, Cancer research.

[40]  Todd R. Golub,et al.  Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Jose J. Galvez,et al.  Comparative pathology of mouse models of human cancers: Genetically engineering a mouse , 2003 .

[42]  R. Cardiff.  Mouse models of human breast cancer. , 2003, Comparative medicine.

[43]  J. Arbeit.  Mouse models of cervical cancer. , 2003, Comparative medicine.

[44]  R. Cardiff,et al.  Mouse strains for prostate tumorigenesis based on genes altered in human prostate cancer. , 2003, Current drug targets.

[45]  K. Washington,et al.  Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.

[46]  Robert D Cardiff,et al.  Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. , 2003, Genes & development.

[47]  T. Mak,et al.  Physiological functions of Pten in mouse tissues. , 2003, Cell structure and function.

[48]  P. Chambon,et al.  Expression of conditional cre recombinase in epithelial tissues of transgenic mice , 2003, Genesis.

[49]  D. Tuveson,et al.  In Search of an Early Warning System for Pancreatic Cancer , 2003, Cancer biology & therapy.

[50]  R. Cardiff,et al.  Validation of Transgenic Mammary Cancer Models: Goals of the NCI Mouse Models of Human Cancer Consortium and the Mammary Cancer CD-ROM , 2002, Transgenic Research.

[51]  Mitchell D Schnall,et al.  Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. , 2002, Cancer cell.

[52]  R. Cardiff,et al.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. , 2002, The American journal of pathology.

[53]  Karlyne M. Reilly,et al.  Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum , 2002, Oncogene.

[54]  Robert D Cardiff,et al.  Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. , 2002, The American journal of pathology.

[55]  R. Cardiff,et al.  Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. , 2002, Cancer research.

[56]  R. Cardiff,et al.  Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors , 2002, Oncogene.

[57]  Jose J. Galvez,et al.  Prostatic intraepithelial neoplasia in genetically engineered mice. , 2002, The American journal of pathology.

[58]  Thierry Soussi,et al.  Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. , 2002, Gastroenterology.

[59]  N. Harris,et al.  Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.

[60]  J. Downing,et al.  Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. , 2002, Blood.

[61]  T. Sugino,et al.  An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. , 2002, The American journal of pathology.

[62]  R. Cardiff,et al.  Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. , 2002, Cancer research.

[63]  S. Barthold.  "Muromics": genomics from the perspective of the laboratory mouse. , 2002, Comparative medicine.

[64]  F. Kittrell,et al.  Biological and genetic properties of the p53 null preneoplastic mammary epithelium , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  Richard Simon,et al.  Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Robert B Boxer,et al.  A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  R. Cardiff,et al.  Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Gregg,et al.  Contributions of mouse biology to breast cancer research. , 2002, Comparative medicine.

[69]  R. Cardiff,et al.  Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[70]  E. Gabrielson,et al.  Functional Genomics, Gene Arrays, and the Future of Pathology , 2001, Modern Pathology.

[71]  R. Cardiff,et al.  Mammary Disease Mice Model Premalignant Polyoma Middle-T Transgenic Updated Version , 2001 .

[72]  R. Cardiff,et al.  Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice , 2001, Oncogene.

[73]  R. Cardiff,et al.  Mammary Cancer in Humans and Mice: A Tutorial for Comparative Pathology , 2001, Veterinary pathology.

[74]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[75]  L. Villarreal,et al.  Natural Biology of Polyomavirus Middle T Antigen , 2001, Microbiology and Molecular Biology Reviews.

[76]  R. Cardiff,et al.  Protein kinase CK2 in mammary gland tumorigenesis , 2001, Oncogene.

[77]  R. Cardiff,et al.  Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. , 2001, Cancer research.

[78]  P. Chaurand,et al.  A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. , 2001, Cancer research.

[79]  M. Moran,et al.  Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer , 2001, Molecular and Cellular Biology.

[80]  R. Cardiff,et al.  Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression , 2001, Molecular and Cellular Biology.

[81]  J. Decaprio,et al.  Cellular transformation by SV40 large T antigen: interaction with host proteins. , 2001, Seminars in cancer biology.

[82]  R. Cardiff,et al.  c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations , 2001, Nature Medicine.

[83]  R. Cardiff,et al.  Validity of Mouse Mammary Tumour Models for Human Breast Cancer: Comparative Pathology , 2022 .

[84]  R. Cardiff,et al.  Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. , 2000, Cancer research.

[85]  Chen-feng Qi,et al.  Burkitt Lymphoma in the Mouse , 2000, The Journal of experimental medicine.

[86]  R. Cardiff,et al.  Genetically Engineered Mouse Models of Mammary Intraepithelial Neoplasia , 2000, Journal of Mammary Gland Biology and Neoplasia.

[87]  K. Hunter,et al.  An epistatic interaction controls the latency of a transgene-induced mammary tumor , 2000, Mammalian Genome.

[88]  E. Andrechek,et al.  Tyrosine kinase signalling in breast cancer: Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer , 2000, Breast Cancer Research.

[89]  R. Cardiff,et al.  Mammary Cancer in Humans and Mice: A Tutorial for Comparative Pathology. The CD-ROM , 2000, Journal of Mammary Gland Biology and Neoplasia.

[90]  M. Rudnicki,et al.  Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[91]  R. Cardiff,et al.  The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.

[92]  F. DeMayo,et al.  MORPHOMETRIC ANALYSIS OF CC10-hASH1 TRANSGENIC MOUSE LUNG: A Model for Bronchiolization of Alveoli and Neuroendocrine Carcinoma , 2000, Experimental lung research.

[93]  A. Balmain,et al.  A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[94]  D. Hanahan,et al.  Tumor Cells Utilize Multiple Pathways to Down‐modulate Apoptosis: Lessons from a Mouse Model of Islet Cell Carcinogenesis , 1999, Annals of the New York Academy of Sciences.

[95]  Joel H. Saltz,et al.  Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. , 1999, Cancer research.

[96]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[97]  P. Musiani,et al.  Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[98]  R. Cardiff,et al.  A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. , 1999, Cancer research.

[99]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[100]  Emmett V Schmidt,et al.  The role of c-myc in cellular growth control , 1999, Oncogene.

[101]  B. Foster,et al.  Pathologic progression of autochthonous prostate cancer in the TRAMP model , 1999, Prostate Cancer and Prostatic Diseases.

[102]  P. Humphrey,et al.  A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J M Ward,et al.  Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.

[104]  R. Cardiff,et al.  Active signaling by Neu in transgenic mice , 1998, Oncogene.

[105]  A. Balmain,et al.  Cancer resistance genes in mice: models for the study of tumour modifiers. , 1998, Trends in genetics : TIG.

[106]  John N. Hutchinson,et al.  Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.

[107]  R. Matusik,et al.  Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[108]  A. Thomson,et al.  Enlargement of the ampullary gland and seminal vesicle, but not the prostate in int-2/Fgf-3 transgenic mice. , 1998, Differentiation; research in biological diversity.

[109]  J. Green,et al.  Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model. , 1998, International journal of oncology.

[110]  R. Cardiff,et al.  Differential expression of the neu transgene in murine mammary tissues. , 1997, International journal of oncology.

[111]  G. Pinkus,et al.  The development of a model for the homing of multiple myeloma cells to human bone marrow. , 1997, Blood.

[112]  R. Cardiff,et al.  Microcirculation and metastasis in a new mouse mammary tumor model system. , 1997, International journal of oncology.

[113]  B. Li,et al.  neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice , 1997, Molecular and cellular biology.

[114]  Bin Chen,et al.  Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice. , 1997, Gene.

[115]  R. Maronpot,et al.  Spontaneous Lesions in Aging FVB/N Mice , 1996, Toxicologic pathology.

[116]  R. Cardiff,et al.  Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. , 1996, The American journal of pathology.

[117]  J. Rosen,et al.  Metastatic prostate cancer in a transgenic mouse. , 1996, Cancer research.

[118]  M. Leach,et al.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.

[119]  R. Cardiff,et al.  Activated neu Induces Rapid Tumor Progression (*) , 1996, The Journal of Biological Chemistry.

[120]  R. Palmiter,et al.  Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. , 1995, Cancer research.

[121]  R. Cardiff,et al.  C-myc protein distribution - mammary adenocarcinomas of mtv/myc transgenic mice. , 1995, International journal of oncology.

[122]  R. Nusse,et al.  Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer. , 1995, Seminars in cancer biology.

[123]  R. Matusik,et al.  Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  C. MacArthur,et al.  Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis , 1995, Journal of virology.

[125]  R. Cardiff,et al.  Comparative pathology of mammary tumorigenesis in transgenic mice. , 1995, Cancer letters.

[126]  P. Leder,et al.  Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[127]  T. van Dyke,et al.  Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen , 1994, Molecular and cellular biology.

[128]  G. Nicolson.  Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis , 1993, Cancer and Metastasis Reviews.

[129]  R. Cardiff,et al.  Multiple tumor types appear in a transgenic mouse with the ras oncogene. , 1993, The American journal of pathology.

[130]  G. V. Vande Woude,et al.  Mos and the cell cycle: the molecular basis of the transformed phenotype. , 1993, Current opinion in genetics & development.

[131]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[132]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[133]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[134]  R. Cardiff,et al.  Transgenic oncogene mice. Tumor phenotype predicts genotype. , 1991, The American journal of pathology.

[135]  M. Barbacid,et al.  Activation of ras oncogenes preceding the onset of neoplasia. , 1990, Science.

[136]  P. Leder,et al.  Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. , 1989, The American journal of pathology.

[137]  P. Jolicoeur,et al.  Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene , 1989, Cell.

[138]  J. Vaage.  A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors , 1989, International journal of cancer.

[139]  H. Zerban,et al.  Significance of Sequential Cellular Changes Inside and Outside Foci of Altered Hepatocytes During Hepatocarcinogenesis∗ , 1989, Toxicologic pathology.

[140]  R. Cardiff,et al.  Harvey-ras mediated neoplastic development in the mouse mammary gland. , 1989, Oncogene.

[141]  R. Cardiff,et al.  Isolation of a pathogenic clone of mouse mammary tumor virus , 1989, Journal of virology.

[142]  R. Cardiff,et al.  Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia. , 1988, Anticancer research.

[143]  R. Cardiff,et al.  c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. , 1988, Oncogene.

[144]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[145]  J. Ward,et al.  Color Atlas of Neoplastic and Non-Neoplastic Lesions in Aging Mice , 1988 .

[146]  D. Hanahan,et al.  Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets , 1988, Cell.

[147]  B. Groner,et al.  Targeted c‐myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. , 1988, The EMBO journal.

[148]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[149]  B. Groner,et al.  Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Cori Bargmann,et al.  The neu oncogene encodes an epidermal growth factor receptor-related protein , 1986, Nature.

[151]  F. Talamantes,et al.  Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. , 1985, Endocrinology.

[152]  P. Shubik.  Progression and promotion. , 1984, Journal of the National Cancer Institute.

[153]  R. Palmiter,et al.  Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors , 1984, Cell.

[154]  S. Aaronson,et al.  Molecular cloning of integrated Gardner-Rasheed feline sarcoma virus: genetic structure of its cell-derived sequence differs from that of other tyrosine kinase-coding onc genes , 1983, Journal of virology.

[155]  P. Leder,et al.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[156]  B. Vennstrom,et al.  Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 , 1982, Journal of virology.

[157]  T. Maloney,et al.  Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice. , 1981, Journal of the National Cancer Institute.

[158]  R. Cardiff,et al.  Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules. , 1980, Cancer research.

[159]  H. Varmus,et al.  The vertebrate homolog of the putative transforming gene of avian myelocytomatosis virus: characteristics of the DNA locus and its RNA transcript. , 1980, Virology.

[160]  G. Martin,et al.  Teratocarcinomas and mammalian embryogenesis. , 1980, Science.

[161]  J. Bishop,et al.  DNA and RNA from Uninfected Vertebrate Cells Contain Nucleotide Sequences Related to the Putative Transforming Gene of Avian Myelocytomatosis Virus , 1979, Journal of virology.

[162]  T. Dunn,et al.  Classification of mouse mammary tumors in Dunn's miscellaneous group including recently reported types. , 1979, Journal of the National Cancer Institute.

[163]  R. Cardiff,et al.  Biology of breast preneoplasia , 1977, Cancer.

[164]  B. Henderson,et al.  Spontaneous tumors of aging wild house mice. Incidence, pathology, and C-type virus expression. , 1973, Journal of the National Cancer Institute.

[165]  R. Huebner,et al.  Feline sarcoma virus tumor induction in cats and dogs. , 1971, Journal of the American Veterinary Medical Association.

[166]  R. Huebner,et al.  Experimental Transmission of Feline Fibrosarcoma to Cats and Dogs , 1970, Nature.

[167]  W. Kirsten,et al.  Malignant lymphomas of extrathymic origin induced in rats by murine erythroblastosis virus. , 1969, Journal of the National Cancer Institute.

[168]  G. Theilen,et al.  Transmissible Feline Fibrosarcoma , 1969, Nature.

[169]  L. Foulds,et al.  The natural history of cancer. , 1958, Journal of chronic diseases.

[170]  L. Foulds.  Experimental study of the course and regulation of tumour growth. , 1951, Annals of the Royal College of Surgeons of England.

[171]  K. Ulesko-Stroganowa.  Die epithelialen Geschwülste der Mäuse. , 1913, Journal of Cancer Research and Clinical Oncology.

[172]  R. Cardiff.  The biology of mammary transgenes: Five rules , 2005, Journal of Mammary Gland Biology and Neoplasia.

[173]  R. Cardiff,et al.  The Comparative Pathology of Human and Mouse Mammary Glands , 2004, Journal of mammary gland biology and neoplasia.

[174]  J. Pollard,et al.  Macrophages: modulators of breast cancer progression. , 2004, Novartis Foundation symposium.

[175]  R. Cardiff,et al.  Signaling Exacerbates Mammary Gland Tumor Development Γ Ppar Material Supplemental , 2022 .

[176]  K. Svenson,et al.  Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. , 1998, Experimental lung research.

[177]  Furth Pa.  SV40 rodent tumour models as paradigms of human disease: transgenic mouse models. , 1998 .

[178]  R. Cardiff,et al.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. , 1994, Genes & development.

[179]  R. Cardiff,et al.  Transgenic mouse models of mammary tumorigenesis. , 1993, Cancer surveys.

[180]  R. Cardiff,et al.  Mammary Morphogenesis and Oncogenes , 1992 .

[181]  R S Weinstein,et al.  Telepathology. Long-distance diagnosis. , 1989, American journal of clinical pathology.

[182]  R. Cardiff.  Cellular and molecular aspects of neoplastic progression in the mammary gland. , 1988, European journal of cancer & clinical oncology.

[183]  I. Verma,et al.  The fos oncogene. , 1987, Advances in cancer research.

[184]  R. Cardiff,et al.  Mammary tumors in feral mice lacking MuMTV DNA. , 1985, Journal of experimental pathology.

[185]  R. Cardiff.  Protoneoplasia: the molecular biology of murine mammary hyperplasia. , 1984, Advances in cancer research.

[186]  L. C. Stevens.  Teratocarcinogenesis and spontaneous parthenogenesis in mice. , 1975, The ... Symposium. Society for Developmental Biology. Symposium.

[187]  T. C. Jones,et al.  ANIMAL MODELS OF HUMAN DISEASE , 2009 .

[188]  P. Buckley,et al.  A comparative study in vitro of a simian virus isolated from spontaneous woolly monkey fibrosarcoma and of a known feline fibrosarcoma virus. , 1973, Bibliotheca haematologica.

[189]  P. Blair,et al.  The mammary tumor virus (MTV). , 1968, Current topics in microbiology and immunology.

[190]  S. Crawley,et al.  Pathology, and , 2022 .